Kaplan Fox Notifies Embecta Corp. (EMBC) Investors of an Upcoming Lead Plaintiff Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC) on behalf of investors that purchased or otherwise acquired Embecta securities between November 25, 2025 and May 4, 2026 (the "Class Period"). If you are an investor in Embecta and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than August 17, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery. On May 5, 2026, Embecta reported its second quarter fiscal 2026 financial results for the period ending March 31, 2026. The press release stated "[w]e were disappointed with our second quarter results as they were significantly below our expectations." Among other things, Embecta reported second quarter 2026 adjusted earnings per share of $0.27 compared to $0.70 in the prior year period and reduced its fiscal 2026 revenue guidance to a range of between $1.015 billion and $1.035 billion from its previous guidance range of between $1.071 billion and $1.093 billion. Following this news, the price of Embecta stock fell $5.35 per share, over 57%, to close at $3.90 per share. The complaint alleges, among other things, that Defendants "knew or recklessly disregarded that segment weakness, especially in the United States pen needle market, was likely to disrupt the Company's original revenue guidance and second quarter 2026 results," yet "management reaffirmed guidance during the Company's first quarter 2026 earnings call . . . ." WHY CONTACT KAPLAN FOX? Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented. Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch. For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.